BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25105219)

  • 1. 'The BRCA clock is ticking!': negotiating medical concerns and reproductive goals in preimplantation genetic diagnosis.
    Rubin LR; Werner-Lin A; Sagi M; Cholst I; Stern R; Lilienthal D; Hurley K
    Hum Fertil (Camb); 2014 Sep; 17(3):159-64. PubMed ID: 25105219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors.
    Derks-Smeets IA; de Die-Smulders CE; Mackens S; van Golde R; Paulussen AD; Dreesen J; Tournaye H; Verdyck P; Tjan-Heijnen VC; Meijer-Hoogeveen M; De Greve J; Geraedts J; De Rycke M; Bonduelle M; Verpoest WM
    Breast Cancer Res Treat; 2014 Jun; 145(3):673-81. PubMed ID: 24748567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.
    Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL
    Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
    Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
    Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
    Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
    Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.
    Hurley K; Rubin LR; Werner-Lin A; Sagi M; Kemel Y; Stern R; Phillips A; Cholst I; Kauff N; Offit K
    Cancer; 2012 Dec; 118(24):6270-7. PubMed ID: 22736296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers.
    Mor P; Brennenstuhl S; Metcalfe KA
    J Genet Couns; 2018 Dec; 27(6):1386-1394. PubMed ID: 29858758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
    Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
    J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performing and Declining PGD: Accounts of Jewish Israeli Women Who Carry a BRCA1/2 Mutation or Partners of Male Mutation Carriers.
    Dagan E; Birenbaum-Carmeli D; Friedman E; Feldman B
    J Genet Couns; 2017 Oct; 26(5):1070-1079. PubMed ID: 28265801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preimplantation genetic diagnosis for BRCA1/2--a novel clinical experience.
    Sagi M; Weinberg N; Eilat A; Aizenman E; Werner M; Girsh E; Siminovsky Y; Abeliovich D; Peretz T; Simon A; Laufer N
    Prenat Diagn; 2009 May; 29(5):508-13. PubMed ID: 19248143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers.
    Drüsedau M; Dreesen JC; Derks-Smeets I; Coonen E; van Golde R; van Echten-Arends J; Kastrop PM; Blok MJ; Gómez-García E; Geraedts JP; Smeets HJ; de Die-Smulders CE; Paulussen AD
    Eur J Hum Genet; 2013 Dec; 21(12):1361-8. PubMed ID: 23531862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.
    Woodson AH; Muse KI; Lin H; Jackson M; Mattair DN; Schover L; Woodard T; McKenzie L; Theriault RL; Hortobágyi GN; Arun B; Peterson SK; Profato J; Litton JK
    Oncologist; 2014 Aug; 19(8):797-804. PubMed ID: 24951607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
    Julian-Reynier C; Fabre R; Coupier I; Stoppa-Lyonnet D; Lasset C; Caron O; Mouret-Fourme E; Berthet P; Faivre L; Frenay M; Gesta P; Gladieff L; Bouhnik AD; Protière C; Noguès C
    Genet Med; 2012 May; 14(5):527-34. PubMed ID: 22241105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.
    Menon U; Harper J; Sharma A; Fraser L; Burnell M; ElMasry K; Rodeck C; Jacobs I
    Hum Reprod; 2007 Jun; 22(6):1573-7. PubMed ID: 17428877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer.
    Quinn GP; Vadaparampil ST; Miree CA; Lee JH; Zhao X; Friedman S; Yi S; Mayer J
    Hum Reprod; 2010 Oct; 25(10):2543-50. PubMed ID: 20713415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "My funky genetics": BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies.
    Werner-Lin A; Rubin LR; Doyle M; Stern R; Savin K; Hurley K; Sagi M
    Fam Syst Health; 2012 Jun; 30(2):166-80. PubMed ID: 22709328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-based predictors of germ-line BRCA1 mutations: implications for triaging of genetic testing.
    de la Cruz J; Andre F; Harrell RK; Bassett RL; Arun B; Mathieu MC; Delaloge S; Gilcrease MZ
    Hum Pathol; 2012 Nov; 43(11):1932-9. PubMed ID: 22591913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Having a child and PND/PGD access in women with a BRCA1/2 mutation? Different approach whether ill or healthy].
    Pellegrini I; Prodromou N; Coupier I; Huiart L; Moretta J; Noguès C; Julian-Reynier C
    Bull Cancer; 2014 Nov; 101(11):1001-8. PubMed ID: 25418592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers.
    Rashid MU; Torres D; Zaidi A; Rasheed F; Sultan F; Shakoori AR; Amin A; Hamann U
    Breast Cancer Res Treat; 2008 Jan; 107(1):155-6. PubMed ID: 18043900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.